Related Experiment Videos
Guideline for prophylactic anticoagulation
Insights
Prophylactic anticoagulation is under-prescribed in South Africa, leading to poor patient outcomes. This guideline aims to improve the use of anticoagulation for medical and surgical patients, benefiting those at risk.
Area of Science:
- Thrombosis and Haemostasis
- Clinical Guidelines
- Anticoagulation Therapy
Background:
- Under-prescription of prophylactic anticoagulation in South Africa results in significant patient mortality and morbidity.
- Addresses the critical need for improved thromboprophylaxis strategies in the South African context.
Framework:
- Developed by the Southern African Society of Thrombosis and Haemostasis through comprehensive literature and guideline review.
- Incorporated multidisciplinary expertise from various medical and surgical specialties.
- Ensured objectivity through external international expert adjudication to minimize local bias.
Implementation:
- A consensus-driven guideline for prophylactic anticoagulation in medical and surgical patients has been established.
- The guideline is tailored specifically for the South African healthcare setting.
- Aims to standardize and enhance the application of anticoagulation prophylaxis.
Implications:
- Expected to improve anticoagulation practices across South Africa.
- Directly benefits patient outcomes by reducing preventable mortality and morbidity.
- Provides a crucial resource for healthcare professionals managing thrombotic risk.
Introduction:
Prophylactic anticoagulation in South Africa is unfortunately under-prescribed. This has led to unacceptable mortality and morbidity in numerous patients.
Method:
The Southern African Society of Thrombosis and Haemostasis held two meetings at which all the available literature as well as guidelines from other societies were reviewed. The specialties represented on the committees included Anaesthetics, Cardiology, Clinical Haematology, Critical Care, Gynaecology, Haematopathology, Internal Medicine, Neurology, Orthopaedic Surgery, Pulmonology and Vascular Surgery. A draft document was presented at both meetings, which was altered by consensus agreement. The guidelines were adjudicated by a recognised external international expert to avoid local bias.
Results And Conclusion:
A guideline for prophylaxis in medical and surgical patients has been produced for the South African situation. It is hoped that this will lead to improved anticoagulation practice in this country, which we believe will directly benefit patient outcome.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis IV: Nursing Management
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Pre-Procedural Guidelines for Assessing Blood Pressure